Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways".

Advances in cancer research - 1 Jan 1998

Ellem K A, Schmidt C W, Li C L, Misko I, Kelso A, Sing G, Macdonald G, O'Rourke M G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen-Antibody Reactions
Share to Disease Progression
Share to Genome, Human
Share to Immunity, Cellular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Mutation

Share to Neoplasms

Share to T-Lymphocytes

Source

Identifiers

PMID: 9709811
DOI: 10.1016/s0065-230x(08)60743-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways".PMID 9709811Read ↗

Cancer management in the era of immunotherapy: much more than meets the eye.Semantic proximity Read ↗

Cancer Immunotherapy: Whence and Whither.Semantic proximity Read ↗

Cancer T-cell therapy: building the foundation for a cureSemantic proximity Read ↗

Navigating the Immune Maze: Pioneering Strategies for Un-shackling Cancer Immunotherapy ResistanceSemantic proximity Read ↗

When Cancer Cells Become the Enablers of an Antitumor Immune ResponseSemantic proximity Read ↗

Targeting cancer's weaknesses (not its strengths): Therapeutic strategies suggested by the atavistic model.Semantic proximity Read ↗

SnapShot: Cancer immunoediting.Semantic proximity Read ↗

CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foeSemantic proximity Read ↗

Immunotherapy: Adoptive cell therapy simplified.Semantic proximity Read ↗

Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor MicroenvironmentSemantic proximity Read ↗

Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a GlimpseSemantic proximity Read ↗

Killing of tumor cells: A drama in two actsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.